Jennifer Ayers-Ringler

1.2k total citations
18 papers, 918 citations indexed

About

Jennifer Ayers-Ringler is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jennifer Ayers-Ringler has authored 18 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Genetics and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jennifer Ayers-Ringler's work include Glioma Diagnosis and Treatment (3 papers), Lanthanide and Transition Metal Complexes (2 papers) and Hedgehog Signaling Pathway Studies (2 papers). Jennifer Ayers-Ringler is often cited by papers focused on Glioma Diagnosis and Treatment (3 papers), Lanthanide and Transition Metal Complexes (2 papers) and Hedgehog Signaling Pathway Studies (2 papers). Jennifer Ayers-Ringler collaborates with scholars based in United States, Germany and Ireland. Jennifer Ayers-Ringler's co-authors include Scott R. VandenBerg, Mitchel S. Berger, Doo‐Sup Choi, Claudia Petritsch, William A. Weiss, Anders I. Persson, Gabriele Bergers, William B. Stallcup, C. David James and Rebecca DeBoer and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Cell and Scientific Reports.

In The Last Decade

Jennifer Ayers-Ringler

18 papers receiving 902 citations

Peers

Countries citing papers authored by Jennifer Ayers-Ringler

Since Specialization

Citations

This map shows the geographic impact of Jennifer Ayers-Ringler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Ayers-Ringler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Ayers-Ringler more than expected).

Fields of papers citing papers by Jennifer Ayers-Ringler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Ayers-Ringler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Ayers-Ringler. The network helps show where Jennifer Ayers-Ringler may publish in the future.

Co-authorship network of co-authors of Jennifer Ayers-Ringler

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Ayers-Ringler. A scholar is included among the top collaborators of Jennifer Ayers-Ringler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Ayers-Ringler. Jennifer Ayers-Ringler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Evaluating therapeutic plasma exchange and protease inhibitors as mechanisms to reduce soluble mesothelin 2025 ·Scientific Reports ·Katherine E. Smith, Jennifer Ayers-Ringler, Jacob J. Orme, Fabrice Lucien, Yohan Kim, Jeffrey L. Winters, Aaron S. Mansfield	1
2	Proteolysis targeting chimera (PROTAC)-driven antibody internalization of oncogenic cell surface receptors 2024 ·Communications Biology ·Ezequiel J. Tolosa, Lin Yang, Jennifer Ayers-Ringler, Shinichiro Suzuki, Jayapal Reddy Mallareddy, Janet Schaefer-Klein, Mitesh J. Borad, Farhad Kosari, Amarnath Natarajan, Aaron S. Mansfield	3
3	Soluble mesothelin neutralizes mesothelin antibody-based therapies. 2024 ·Journal of Clinical Oncology ·Katherine E. Smith, Jennifer Ayers-Ringler, (unknown), Fabrice Lucien, (unknown), Jacob J. Orme, Jeffrey L. Winters, Jeffrey A. Moscow, Aaron S. Mansfield	1
4	Neurologic Effects of Gadolinium Retention in the Brain after Gadolinium-based Contrast Agent Administration 2021 ·Radiology ·Jennifer Ayers-Ringler, Jennifer S. McDonald, (unknown), (unknown), (unknown), Daniel R. Jakaitis, (unknown), (unknown), (unknown), Daying Dai, Doo‐Sup Choi, Jeffrey L. Salisbury, Paul J. Jannetto, Joshua A. Bornhorst, (unknown), David F. Kallmes, Robert J. McDonald	22
5	Proteomic Analysis of Cardioembolic and Large Artery Atherosclerotic Clots Using Reverse Phase Protein Array Technology Reveals Key Cellular Interactions Within Clot Microenvironments 2021 ·Cureus ·Mehdi Abbasi, Seán Fitzgerald, Jennifer Ayers-Ringler, Virginia Espina, Claudius Mueller, (unknown), Ramanathan Kadirvel, David F. Kallmes, Waleed Brinjikji	9
6	Gadolinium retention within multiple rat organs after intra-articular administration of gadolinium-based contrast agents 2021 ·Skeletal Radiology ·Michael D. Ringler, Nicholas G. Rhodes, Jennifer Ayers-Ringler, Daniel R. Jakaitis, Robert J. McDonald, David F. Kallmes, Jennifer S. McDonald	9
7	L-Arginine reduces downstream vascular contractility after flow-diverting device deployment: A preliminary study in a rabbit model 2021 ·Interventional Neuroradiology ·Jennifer Ayers-Ringler, (unknown), (unknown), Daying Dai, Yonghong Ding, David F. Kallmes, Ramanathan Kadirvel	2
8	Differential SLC1A2 Promoter Methylation in Bipolar Disorder With or Without Addiction 2017 ·Frontiers in Cellular Neuroscience ·Yun‐Fang Jia, (unknown), Jennifer Ayers-Ringler, Joanna M. Biernacka, Jennifer R. Geske, (unknown), Susan L. McElroy, Mark A. Frye, Doo‐Sup Choi, Marin Veldić	23
9	450. In Bipolar Disorder, SLC1A2 Promoter Hypomethylation is Associated with Binge Eating Disorder and Nicotine Dependance 2017 ·Biological Psychiatry ·Marin Veldić, Yun‐Fang Jia, (unknown), Jennifer Ayers-Ringler, Joanna M. Biernacka, Jennifer R. Geske, Susan L. McElroy, Mark A. Frye, Doo‐Sup Choi	2
10	Antipsychotic-like effects of a neurotensin receptor type 1 agonist 2016 ·Behavioural Brain Research ·Chelsea A. Vadnie, Jennifer Ayers-Ringler, Alfredo Oliveros, Osama A. Abulseoud, Sun Choi, Mario J. Hitschfeld, Doo‐Sup Choi	23
11	Label-Free Proteomic Analysis of Protein Changes in the Striatum during Chronic Ethanol Use and Early Withdrawal 2016 ·Frontiers in Behavioral Neuroscience ·Jennifer Ayers-Ringler, Alfredo Oliveros, Yanyan Qiu, Daniel M. Lindberg, David J. Hinton, Raymond M. Moore, Surendra Dasari, Doo‐Sup Choi	29
12	Role of astrocytic glutamate transporter in alcohol use disorder 2016 ·World Journal of Psychiatry ·Jennifer Ayers-Ringler, Yun‐Fang Jia, Yanyan Qiu, Doo‐Sup Choi	32
13	Purinergic Signaling and Energy Homeostasis in Psychiatric Disorders 2015 ·Current Molecular Medicine ·Daniel M. Lindberg, Dan Shan, Jennifer Ayers-Ringler, Alfredo Oliveros, (unknown), Miguel L. Prieto, Robert E. McCullumsmith, Doo‐Sup Choi	47
14	Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures 2014 ·Glia ·Charles L. Howe, Tatiana Kaptzan, Setty M. Magaña, Jennifer Ayers-Ringler, Reghann G. LaFrance‐Corey, Claudia F. Lucchinetti	73
15	Asymmetry-Defective Oligodendrocyte Progenitors Are Glioma Precursors 2011 ·Cancer Cell ·(unknown), Anders I. Persson, Elena González-Muñoz, (unknown), Chrystelle Lamagna, Noemi Andor, (unknown), Jennifer Ayers-Ringler, Joanna J. Phillips, Jason J. Siu, Daniel A. Lim, Scott R. VandenBerg, William B. Stallcup, Mitchel S. Berger, Gabriele Bergers, William A. Weiss, Claudia Petritsch	171
16	Non-Stem Cell Origin for Oligodendroglioma 2010 ·Cancer Cell ·Anders I. Persson, Claudia Petritsch, Fredrik J. Swartling, Melissa Itsara, Fraser J. Sim, Romane Auvergne, David Goldenberg, Scott R. VandenBerg, Kim Nguyễn, (unknown), Jennifer Ayers-Ringler, Akiko Nishiyama, William B. Stallcup, Mitchel S. Berger, Gabriele Bergers, Tracy R. McKnight, Steven A. Goldman, William A. Weiss	167
17	Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing 2010 ·Neuro-Oncology ·Rintaro Hashizume, Nalin Gupta, Mitchel S. Berger, Anu Banerjee, (unknown), Jennifer Ayers-Ringler, C. David James, Scott R. VandenBerg	18
18	Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma 2008 ·Journal of Clinical Oncology ·Michael D. Prados, Susan M. Chang, Nicholas Butowski, Rebecca DeBoer, Rupa Parvataneni, Hannah Carliner, (unknown), Jennifer Ayers-Ringler, Jane Rabbitt, Margaretta Page, Anne Fedoroff, Penny K. Sneed, Mitchel S. Berger, Michael W. McDermott, Andrew T. Parsa, Scott R. VandenBerg, C. David James, Kathleen R. Lamborn, David Stokoe, Daphne A. Haas‐Kogan	286

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact